Core Viewpoint - Aibo Medical has a strong market share and leading position in the ophthalmic surgery and myopia prevention market in China, with a rapidly growing vision care business and plans to expand into high-comfort, functional consumer products [1] Group 1 - The company has a high market share in the ophthalmic surgery and myopia prevention market in China [1] - The vision care business is currently in a rapid growth phase [1] - The company is accelerating its expansion into high-comfort and functional consumer product markets [1]

Group 1 - The company, Aibo Medical (688050.SH), holds a significant market share and leading position in the ophthalmic surgery and myopia prevention market in China [1] - The vision care business is currently experiencing rapid growth and is accelerating its expansion into high comfort and functional consumer product markets [1] - The company expresses strong confidence in its future development and will continue to actively promote market expansion [1]

Group 1 - The company has a high market share and leading position in the ophthalmic surgery and myopia prevention market in China [1] - The vision care business is experiencing rapid growth and is accelerating its expansion into high comfort and functional consumer product markets [1] - The company is confident about its future development and will continue to actively promote market expansion [1]